EcoR1 Capital, LLC, Director, 10% Owner at Zymeworks Inc. (ZYME), bought 726,738 shares at $14.47 ($10.6M) on 2024-12-30, disclosed to the SEC on 2025-01-02.
Open-market purchase of $10.6M ZYME by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.47 | 58,988 | $854K | 8.0% |
| 2 | $14.47 | 58,988 | $854K | 8.0% |
| 3 | $14.57 | 146,501 | $2.1M | 20.1% |
| 4 | $14.57 | 146,501 | $2.1M | 20.1% |
| 5 | $14.78 | 157,880 | $2.3M | 21.9% |
| 6 | $14.78 | 157,880 |
| $2.3M |
| 21.9% |
| Total | $14.65 avg | 726,738 | $10.6M | 100% |
| Filing → |
| AKTS | BUY | 2026-01-12 | $40.0M | — | Filing → |
| ADAP | SELL | 2025-07-30 | $13.2M | — | Filing → |
| ZYME | BUY | 2025-05-19 | $1.3M | — | Filing → |